BIOSYNTHETIC HEPARIN

The present disclosure relates to synthesis of heparin, which may be bioequivalent to porcine USP Heparin Sodium. The synthesis may involve three intermediates starting from heparosan.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PASKALEVA, ELENA, LI, KEVIN, DATTA, PAYEL, DOUAISI, MARC, DORDICK, JONATHAN, GROVER, NAVDEEP, BRODFUEHRER, PAUL, LIN, LEI, HIRAKANE, MAKOTO, ONISHI, AKIHIRO, FU, LI, SIMMONS, TREVOR J, LINHARDT, ROBERT J, MORI, DAISUKE
Format:	Patent
Sprache:	eng ; pol
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to synthesis of heparin, which may be bioequivalent to porcine USP Heparin Sodium. The synthesis may involve three intermediates starting from heparosan.